You searched for "ESCRS"

371 results found

Towards virtual reality conferences?

COVID-19 is forcing us to reconsider every aspect of life. The authors ask what future ophthalmic meetings could look like. The coronavirus disease COVID-19 pandemic disrupted ophthalmic conferences resulting in the cancellation of the majority of meetings in 2020, e.g....

Intracameral antibiotics in cataract surgery: current evidence base

Following on from our recent online survey*, the authors examine the use of intracameral cefuroxime as the standard of care in cataract surgery. Cataract extraction with intraocular lens implantation is one of the most frequently performed surgical procedures in the...

I have to be here…

Apparently, I’ve been known to attend the occasional eye conference! I firmly believe that such events broaden the mind and help maintain a love of our specialty through community. There are many lessons to be learned at such congresses, and...

Optos announces new ultra-widefield colour image modality, providing additional retinal visualisation to eyecare professionals

Optos, Plc, the leading retinal imaging company, announces it is expanding the optomap® ultra-widefield (UWF™) retinal imaging modalities available with the California FA device to further assist eyecare professionals in disease management and treatment planning.

Practical application of cataract risk stratification

This study assessed the practicability of a risk stratification system, the New Zealand Cataract Risk Stratification (NZCRS) in a major teaching hospital. The scoring system was as follows: three points for Dense cataract, pseudoexfoliation (PXF), phacodonesis, previous vitrectomy and only...

Learning from litigation: ocular drug toxicity

Being the subject of litigation is stressful and upsetting. Having to look back over your previous decisions and justify the care you delivered in good faith can be difficult. Sadly, we all live with the sword of Damocles above us...

Alcon UK and Ireland announces launch of Clareon® PanOptix® Pro

- Sponsored Content - Alcon UK and Ireland announces launch of Clareon® PanOptix® Pro: Delivering a Light Experience Like Never Before in a Trifocal IOL1-7 , ¥ – now with less light scatter1,2,8-9 , * Clareon® PanOptix® Pro delivers: •...

Stem cell therapy for Parkinson’s disease: researching for an 
effective cure

Neurodegenerative diseases are characterised by the chronic and progressive loss of neurons, which in turn results in loss of cognitive and physical functions. The World Health Organization has estimated that the disability-adjusted life years lost from neurological disease was about...

A short survey of the views of clinicians on the role of procedure-specific consent forms

Informed consent is an ethical and legal right of every patient [1]. It is essential that patients receive clear, concise and accurate information regarding the risks, benefits and alternatives to a potential intervention. In addition to this, the patient must...

Preoperative povidone iodine: weighing the risks

Following on from our recent online survey, the authors examine the potential risks and benefits of diluting the concentration preoperative povidone iodine. Povidone iodine (PI) is an iodophore that has an established use as a broad-spectrum antiseptic, mainly for the...

75th Anniversary year of the first intraocular lens implant

The 29th of November 2024 marks the 75th anniversary of the first intraocular lens implant by our Founder, Sir Harold Ridley FRS. The United Kingdom & Ireland Society of Cataract & Refractive Surgeons (UKISCRS) is marking the event with a...

Intraocular lens choice in patients who have undergone previous corneal refractive surgery

Patients who underwent vision correction in their 20s to 40s are now entering their 50s and 60s, the typical starting age for cataract development [1]. Consequently, ophthalmologists are increasingly encountering patients whose corneal profiles have been surgically altered, requiring advanced...